Clinical trial
A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED TRIAL TO EVALUATE G7 Acetabular System With CoC ARTICULATION COMPARED TO EXCEED ABT Acetabular System With CoC ARTICULATION IN TOTAL HIP ARTHROPLASTY
NCT02340390 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED TRIAL TO EVALUATE G7 Acetabular System With CoC ARTICULATION COMPARED TO EXCEED ABT Acetabular System With CoC ARTICULATION IN TOTAL HIP ARTHROPLASTY
- Lead sponsor
- Zimmer Biomet
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2015
- Completion date
- November 30, 2018
- Enrollment
- 160 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis arthritis, rheumatoid arthritis